Skip to main content

Year: 2022

Cryptyde’s Recent Acquisition of Forever 8 Offers A Solution to Inventory Capital

SAFETY HARBOR, Florida, Nov. 15, 2022 (GLOBE NEWSWIRE) — With Cryptyde’s (Nasdaq:TYDE) acquisition of Forever 8 Fund, LLC (“Forever 8”) now complete, the company intends to aggressively pursue the $5 trillion dollar e-commerce market1, approximately $600 billion2 of which represents Amazon Global and its third-party sellers, Forever 8’s primary sales channel. Forever 8’s distinct business model provides an inventory purchasing solution for e-commerce sellers to effectively operate their business without the need to dedicate time and resources towards financing. Forever 8 creates a favorable environment for the seller to scale their business while mitigating the risk that a traditional factoring, merchant cash advance and a revenue-based financing program faces when engaging a potential client. Through utilization of a proprietary...

Continue reading

BioStem Technologies to Host Third Quarter Financial Results and Corporate Update Conference Call

POMPANO BEACH, FLORIDA., Nov. 15, 2022 (GLOBE NEWSWIRE) — BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics, today announced it will host a conference call to discuss financial results for the quarter ended September 30, 2022 and provide a corporate update on Tuesday, November 15, 2022, at 4:30 pm EST. Conference Call Details Date: Tuesday, November 15, 2022Time: 4:30 pm ESTWebcast Link: https://events.q4inc.com/attendee/534919982Conference ID: 4373739Participant Toll-Free Dial-In Number: 1 (888) 880-2204Participant Toll Dial-In Number: 1 (646) 960-0414 In order to submit questions, participants must have Internet connectivity, as questions will only be addressed via the webcast. The conference call line will...

Continue reading

InspireSemi Announces Third Quarter 2022 Business Update and Financial Results Conference Call

Call Scheduled for Tuesday, November 22, 2022 at 10:00 am ET AUSTIN, Texas, Nov. 15, 2022 (GLOBE NEWSWIRE) — Inspire Semiconductor Holdings Inc. (TSXV: INSP) (“InspireSemi” or the “Company”), a chip design company that has built a technology foundation to deliver revolutionary performance, today announced that it plans to release financial results for the third quarter ended September 30, 2022 after market close on Monday, November 21, 2022. The Company will host a conference call on Tuesday, November 22, 2022 at 10:00 am (Eastern Time) to discuss the results and provide a business update.Event:   InspireSemi Announces Third Quarter 2022 Business Update and Financial Results Conference CallDate:   Tuesday, November 22, 2022Time:   10:00 am Eastern TimeLive Call:   +1-877-407-9039 (U.S. Toll-Free) or +1-201-689-8470...

Continue reading

Consolidated Uranium Announces Acquisition of Virginia Energy Resources, Securing the Largest Undeveloped Uranium Deposit in the U.S.

Figure 1 Coles Hill Property LocationFigure 2 Long Section of the Coles Hill Uranium Deposit 3TORONTO, Nov. 15, 2022 (GLOBE NEWSWIRE) — Consolidated Uranium Inc. (“CUR”, “Consolidated Uranium”) (TSXV: CUR) (OTCQB: CURUF) and Virginia Energy Resources Inc. (TSXV: VUI) (“Virginia Energy”) are pleased to announce that they have entered into a definitive agreement (the “Arrangement Agreement”) pursuant to which Consolidated Uranium will acquire all of the issued and outstanding common shares of Virginia Energy (the “Virginia Energy Shares”) by way of a court-approved plan of arrangement (the “Transaction”). Virginia Energy owns 100% of the Coles Hill Uranium Project (“Coles Hill” or the “Project”) located in south central Virginia, United States, which is the largest undeveloped uranium deposit in the U.S. and among the largest...

Continue reading

Welding Market Size Worth USD 28.66 Billion, Globally, by 2028 at 4.6% CAGR

According to Fortune Business Insights, the global Welding market size is projected to grow from USD 20.23 billion in 2020 to USD 28.66 billion in 2028, at CAGR of 4.6% during forecast period; Pune, India, Nov. 15, 2022 (GLOBE NEWSWIRE) — The global Welding Market was USD 20.23 billion in 2020. The global market size is expected to grow from USD 20.99 billion in 2021 and projected to reach USD 28.66 billion by 2028, exhibiting a CAGR of 4.6% during the forecast period from 2021-2028. This information is provided by Fortune Business Insights, in its report, titled, “Welding Market, 2021-2028.” According to our analysts, the welding industry has progressed considerably over the last few years, along with a broadened application opportunity, navigated by advancements in gears linked with the procedure. Similarly, scarcity of welders...

Continue reading

GXO Deploys Most Technology in Its History

Following record year of customer sales wins, technology deployments in North America and Europe to be over 50% higher in 2022 than in 2021 Robotics and collaborative robots help optimize operations, reduce costs, improve safety during busiest time of year for logistics industry GREENWICH, Conn., Nov. 15, 2022 (GLOBE NEWSWIRE) — (NYSE: GXO), the world’s largest pure-play contract logistics provider, announced today that it’s deploying more robotics innovation and technology to support customer start-ups and the holiday peak season than in any other quarter in its history. By the end of the year, GXO will have approximately 7,600 pieces of technology operational in customer sites around the globe, including cobots and robots, vision scanners, automated guided vehicles (AGVs) and goods-to-person robots — up more than 50% over the...

Continue reading

Amarin Announces VAZKEPA® (icosapent ethyl) Approved by the Therapeutic Goods Administration (TGA) in Australia

— VAZKEPA® Approved in Australia to Reduce the Risk of CV Events in Adult Statin-Treated Patients with High CV Risk with Elevated Triglycerides — — Marks Fifth Regulatory Approval for VASCEPA®/VAZKEPA® Franchise in Key International Markets in 2022 — DUBLIN, Ireland and BRIDGEWATER, N.J., Nov. 15, 2022 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) today announced that Australia’s Therapeutic Good Administration (TGA) has granted approval to VAZKEPA (icosapent ethyl). The TGA approved VAZKEPA to reduce the risk of cardiovascular (CV) events in adult statin-treated patients with high CV risk with elevated triglycerides in Australia. Dyslipidemia is a significant healthcare issue for patients in Australia. According to estimates from the most recent large-scale biomedical survey of the Australian...

Continue reading

73 Percent of Shoppers Prefer to Make Purchases on Their Mobile Phones After Visiting a Store, Says New Research from Sinch

sinch_retail_cx_report__PR_thumbnail_image_1300x780 (002) Man on phone making a payment remotely sinch_retail_cx_report__PR_thumbnail_image_1300x780 (002)  73 Percent of Shoppers Prefer to Make Purchases on Their Mobile Phones After Visiting a Store, Says New Research from Sinch In A Hybrid World, Shoppers Are Selecting Retailers That Blend In-Store Experiences with Digital Conveniences Built On Conversational Messaging STOCKHOLM, Sweden, and ATLANTA — November 15th, 2022 — Entering the 2022 holiday season, consumers are increasingly embracing a hybrid shopping experience that couples in-store visits with digital tools that optimize the buying process, according to a global survey of nearly 3,000 customers commissioned by Sinch (Sinch AB (publ) – XSTO: SINCH). Shoppers prefer retailers that super-charge the in-person experience by...

Continue reading

ValOre RC Drilling, Soil Sampling Geochemistry and Kilometre-Scale VLF-EM Conductors Showcase Regional Exploration Potential at Dipole and RIB Targets, Angilak Property Uranium Project, Nunavut, Canada

Significant Results include 7.6 m @ 0.594% U3O8 and 5.97 g/t Ag from 47.2 m, including 1.52 m @ 2.21% U3O8 and 16.5 g/t Ag from 48.8 m.Figure 1: Plan map of Dipole target. Figure 1: Plan map of Dipole target.Figure 2: Cross section A-A’, Dipole target. Figure 2: Cross section A-A’, Dipole target.Figure 3: Enzyme Leach soils geochemistry at the Dipole and RIB targets, showing 2022 and historical data. Figure 3: Enzyme Leach soils geochemistry at the Dipole and RIB targets, showing 2022 and historical data.Figure 4: Plan map of Dipole and RIB targets, showing new ground VLF-EM and extensions to the prospective conductor trends. Figure 4: Plan map of Dipole and RIB targets, showing new ground VLF-EM and extensions to the prospective conductor trends.VANCOUVER, British Columbia, Nov. 15, 2022 (GLOBE NEWSWIRE) — ValOre...

Continue reading

Microbot Medical Announces New Webinar Series to Engage Stakeholders with Experts in the Healthcare Space

The “Access-Ability Live” by MBOT will build an online community of healthcare industry leaders who are interested in robotics to come together and share their opinion and experience First Webinar on November 16th at 1:00 pm ET will Focus on the Evolving Endovascular Space Procedures and How Emerging New Technologies such as the LIBERTY® Robotic System may be used by Physicians in the Future HINGHAM, Mass., Nov. 15, 2022 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), announced that it will be hosting a monthly educational webinar series, the Access-Ability Live by MBOT, to focus on key issues impacting the future of the endovascular space, including robotics and other medical devices that will improve patient outcomes, and the place that the LIBERTY® Robotic System is expected to play in it. Each month, the Company plans...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.